Significance of serum hepcidin in assessment of liver inflammation activity among patients with chronic hepatitis B
10.19485/j.cnki.issn2096-5087.2022.03.005
- Author:
Yinfei HU
;
Tao HE
;
Yunxia FEI
;
Xiangbo ZHANG
;
Jie WANG
;
Ling GONG
;
Xiaoben PAN
;
Gongyin CHEN
- Publication Type:Journal Article
- Keywords:
chronic hepatitis B;
iron metabolism disorder;
hepcidin;
inflammation activity
- From:
Journal of Preventive Medicine
2022;34(3):240-243
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the value of serum hepcidin in assessment of liver inflammation activity among patients with chronic hepatitis B ( CHB ), so as to provide insights into the assessment of liver inflammation activity among CHB patients.
Methods:A total of 79 CHB patients who were admitted to the Affiliated Hospital of Hangzhou Normal University were selected as the experimental group, while 40 healthy volunteers were randomly sampled as controls. Subjects'demographic data, liver function tests and iron metabolism parameters were collected from medical records, and serum hepcidin was measured using enzyme-linked immunosorbent assay ( ELISA ). In addition, ultrasound-guided liver biopsy was performed in CHB patients, and mild and moderate-to-severe CHB were classified according to liver inflammation activity and degree of liver fibrosis. Serum hepcidin levels were compared between the experimental and control groups and between patients with mild and moderate-to-severe CHB. The value of serum hepcidin in assessment of liver inflammation activity was examined among CHB patients using the receiver operating characteristic ( ROC ) curve analysis.
Results:Subjects in the experimental group included 54 men ( 68.35% ) and had a mean age of ( 39.06±10.67 ) years, while the controls included 24 men (60.00%) and had a mean age of ( 42.43±11.44 ) years. Lower hepcidin levels were measured in the experimental group than in the control group [( 11.70±5.64 ) vs. ( 17.82±3.63 ) μg/L; P<0.05 ]. There were 54 patients with mild CHB ( 68.35% ) and 25 cases with moderate-to-severe CHB ( 31.65% ), and lower hepcidin levels were detected in patients with moderate-to-severe CHB than in those with mild CHB [ ( 6.92±2.21 ) vs. ( 13.95±5.36 ) μg/L; P<0.05 ]. The area under the ROC curve, optimal cut-off, sensitivity and specificity of serum hepcidin were 0.903 ( P<0.05 ), 10.365 μg/L, 100.0% and 72.2% for assessment of moderate-to-severe CHB, respectively.
Conclusion:Serum hepcidin is feasible to evaluate the liver inflammatory activity among patients with CHB.
- Full text:血清铁调素评估慢性乙肝患者肝组织炎症活动度研究.pdf
